康臣药业(01681)1月16日注销838.5万股已购回股份

Core Viewpoint - Kangchen Pharmaceutical (01681) announced a share buyback plan from October 14, 2025, to December 17, 2025, with the intention to cancel 8.385 million shares on January 16, 2026 [1] Summary by Category - Company Actions - The company plans to repurchase shares during the specified period [1] - A total of 8.385 million shares will be canceled following the buyback [1] - Financial Implications - The share buyback and subsequent cancellation may impact the company's share structure and potentially enhance shareholder value [1]